Taiwan · Delayed Price · Currency is TWD BioGend Therapeutics Statistics
Total Valuation
TPEX:6733 has a market cap or net worth of TWD 3.40 billion. The enterprise value is 2.57 billion.
| Market Cap | 3.40B |
| Enterprise Value | 2.57B |
Important Dates
The next estimated earnings date is Monday, November 9, 2026.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6733 has 134.32 million shares outstanding. The number of shares has increased by 1.75% in one year.
| Current Share Class | 134.32M |
| Shares Outstanding | 134.32M |
| Shares Change (YoY) | +1.75% |
| Shares Change (QoQ) | +6.96% |
| Owned by Insiders (%) | 3.97% |
| Owned by Institutions (%) | 2.37% |
| Float | 67.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.36 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 3.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 32.13, with a Debt / Equity ratio of 0.00.
| Current Ratio | 32.13 |
| Quick Ratio | 31.12 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -685.59 |
Financial Efficiency
Return on equity (ROE) is -8.17% and return on invested capital (ROIC) is -6.11%.
| Return on Equity (ROE) | -8.17% |
| Return on Assets (ROA) | -5.83% |
| Return on Invested Capital (ROIC) | -6.11% |
| Return on Capital Employed (ROCE) | -8.39% |
| Weighted Average Cost of Capital (WACC) | 4.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | 3.16 |
Taxes
| Income Tax | -8.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.78% in the last 52 weeks. The beta is 0.08, so TPEX:6733's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -30.78% |
| 50-Day Moving Average | 25.40 |
| 200-Day Moving Average | 32.84 |
| Relative Strength Index (RSI) | 46.46 |
| Average Volume (20 Days) | 185,172 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6733 had revenue of TWD 236.58 million and -67.84 million in losses. Loss per share was -0.54.
| Revenue | 236.58M |
| Gross Profit | 167.18M |
| Operating Income | -91.87M |
| Pretax Income | -84.55M |
| Net Income | -67.84M |
| EBITDA | -46.22M |
| EBIT | -91.87M |
| Loss Per Share | -0.54 |
Balance Sheet
The company has 849.79 million in cash and 4.76 million in debt, with a net cash position of 845.03 million or 6.29 per share.
| Cash & Cash Equivalents | 849.79M |
| Total Debt | 4.76M |
| Net Cash | 845.03M |
| Net Cash Per Share | 6.29 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 7.95 |
| Working Capital | 940.34M |
Cash Flow
In the last 12 months, operating cash flow was -47.23 million and capital expenditures -2.93 million, giving a free cash flow of -50.17 million.
| Operating Cash Flow | -47.23M |
| Capital Expenditures | -2.93M |
| Depreciation & Amortization | 45.65M |
| Net Borrowing | -3.72M |
| Free Cash Flow | -50.17M |
| FCF Per Share | -0.37 |
Margins
Gross margin is 70.66%, with operating and profit margins of -38.83% and -28.67%.
| Gross Margin | 70.66% |
| Operating Margin | -38.83% |
| Pretax Margin | -35.74% |
| Profit Margin | -28.67% |
| EBITDA Margin | -19.54% |
| EBIT Margin | -38.83% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6733 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.75% |
| Shareholder Yield | -1.75% |
| Earnings Yield | -2.00% |
| FCF Yield | -1.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6733 has an Altman Z-Score of 57.83 and a Piotroski F-Score of 3.
| Altman Z-Score | 57.83 |
| Piotroski F-Score | 3 |